European medicines regulators, including the EMA, are warning against unproven cancer treatments being marketed by shady clinics and companies. These treatments, often labeled as advanced therapy medicinal products (ATMPs), can only be legally offered if authorized by the EMA or part of a clinical trial. Many clinics are exploiting patients' fears by advertising potentially harmful therapies without proper oversight, leading to financial and emotional distress. The EMA urges reporting of such scams and highlights warning signs of unregulated drugs. Teljes cikk (Euronews.com)